Physician profile
Michael R Klein
NPI 1871756379
$5,686.67
in general payments reported to CMS, 2019-2025
15 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.64 · 2021: $105 · 2022: $103 · 2023: $1,332 · 2024: $3,050 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,675 · Food and Beverage: $1,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,675.01 |
| Food and Beverage | $1,733.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,126.01 | 2023-2025 | Evoque, Pascal |
| Abbott Laboratories | $1,762.91 | 2021-2025 | Triclip, Mitraclip |
| Boston Scientific Corporation | $297.55 | 2023-2025 | Watchman Access System, Watchman Flx, Patientcare Link |
| Siemens Medical Solutions USA, INC. | $116.64 | 2024-2025 | Acuson Origin Diagnostic Ultrasound System |
| Amgen INC. | $85.50 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $80.35 | 2022-2025 | Eliquis |
| Medtronic, INC. | $31.18 | 2023 | Corevalve Evolut R |
| Pfizer INC. | $29.29 | 2024-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $28.93 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $28.73 | 2025 | |
| Novartis Pharmaceuticals Corporation | $28.03 | 2021 | |
| Novo Nordisk INC | $23.51 | 2025 | Ozempic |
| Abiomed | $18.81 | 2025 | |
| Heartflow, INC. | $15.18 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.